Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « COVID-19 (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
CD8-Positive T-Lymphocytes (metabolism) < COVID-19 (MeSH) < COVID-19 (blood)  Facettes :

List of bibliographic references indexed by COVID-19 (MeSH)

Number of relevant bibliographic references: 1063.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000028 (2021) X S Wang [République populaire de Chine] ; J H Cai [République populaire de Chine] ; M. Zeng [République populaire de Chine] ; H. Tian [République populaire de Chine] ; H L Chang [République populaire de Chine] ; Y L Ge [République populaire de Chine] ; J J Li [République populaire de Chine] ; Z Q Wei [République populaire de Chine] ; J S Wang [République populaire de Chine][Clinical analysis of liver chemistries in children and adolescent with 2019-nCoV infection].
000066 (2021) Kim Lauper [Suisse, Royaume-Uni] ; Johannes W J. Bijlsma [Pays-Bas] ; Gerd R. Burmester [Allemagne]Trajectories of COVID-19 information in the Annals of the Rheumatic Diseases: the first months of the pandemic.
000072 (2021) Konstantinos Parperis [Chypre (pays), États-Unis]To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (COVID-19) pandemic.
000074 (2021) S Nia Romano [Portugal] ; Heloísa Galante [Portugal] ; Débora Figueira [Portugal] ; Zilda Mendes [Portugal] ; Ant Nio Teixeira Rodrigues [Portugal]Time-trend analysis of medicine sales and shortages during COVID-19 outbreak: Data from community pharmacies.
000086 (2021) Gerard Espinosa [Espagne] ; Sergio Prieto-González [Espagne] ; Mireia Llevadot [Espagne] ; Javier Marco-Hernández [Espagne] ; Antonio Martínez-Artu A [Espagne] ; Albert Pérez-Isidro [Espagne] ; Elia Rifé [Espagne] ; Ricard Cervera [Espagne]The impact of SARS-CoV-2 coronavirus infection in patients with systemic lupus erythematosus from a single center in Catalonia.
000102 (2021) Saeed Ur Rashid Nazir ; Taha Nazir ; Misbah Sultana ; Rahat Shamim ; Humayun Riaz ; Safia Sultana Munir ; Ruqaiya Rasheed Kayani ; Saba Manzoor ; Azharul IslamThe Potentially Recommended Pharmacotherapy for COVID-19.
000109 (2021) Hailey Olds [États-Unis] ; Jesse Liu [États-Unis] ; Kevin Luk [États-Unis] ; Henry W. Lim [États-Unis] ; David Ozog [États-Unis] ; Pranita V. Rambhatla [États-Unis]Telogen effluvium associated with COVID-19 infection.
000110 (2021) Consolato M. Sergi [Canada] ; Brian Chiu [Canada]Targeting NLRP3 inflammasome in an animal model for Coronavirus Disease 2019 (COVID-19) caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
000111 (2021) L. Ratiani ; S. Gegechkory ; K. Machavariani ; T. Shotadze ; T. Sanikidze [Géorgie (pays)] ; N. IntskirveliTHE PECULIARITY OF COVID- 19 GENOME AND THE CORONAVIRUS RNA TRANSLATION PROCESS AS APOTENTIAL TARGET FOR ETIOTROPIC MEDICATIONSWITH ADENINE AND OTHER NUCLEOTIDE ANALOGUES (REVIEW).
000131 (2021) Carmen Magdalena Gamboa-Alonso [Mexique] ; Gabriel Figueroa-Parra [Mexique] ; Dionicio Angel Galarza-Delgado [Mexique]Still early to define a clear role of antimalarial drugs for COVID-19 in patients with rheumatic disease. Response to: 'Hydroxychloroquine reduces the risk of covid-19 in patients with rheumatic diseases: myth or reality?' by Xie et al.
000164 (2021) Mohit Goyal [Oman]SLE patients are not immune to covid-19: importance of sending the right message across.
000167 (2021) Masoomeh Sofian [Iran] ; Ali Akbar Velayati [Iran] ; Mohammad Banifazl [Iran] ; Fatemeh Fotouhi [Iran] ; Mona Sadat Larijani [Iran] ; Neda Afzali [Iran] ; Amitis Ramezani [Iran]SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms.
000182 (2021) Philippe Guilpain [France] ; Clément Le Bihan [France] ; Vincent Foulongne [France] ; Patrice Taourel [France] ; Nathalie Pansu [France] ; Alexandre Thibault Jacques Maria [France] ; Boris Jung [France] ; Romaric Larcher [France] ; Kada Klouche [France] ; Vincent Le Moing [France]Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia.
000192 (2021) Alexis Mathian [France] ; Zahir Amoura [France]Response to: 'Are patients with systemic lupus erythematosus at increased risk for COVID-19?' by Favalli et al.
000193 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Hervé Chaudet [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to uncertain effect of hydroxychloroquine and azithromycin on SARS-CoV-2 viral load.
000194 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Stéphane Honoré [France] ; Yanis Roussel [France] ; Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.
000195 (2021) Philippe Gautret [France] ; Van Thuan Hoang [Viêt Nam] ; Jean-Christophe Lagier [France] ; Didier Raoult [France]Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.
000197 (2021) Paolo Agostinis [Italie] ; Valentina Vianello [Italie] ; Elena Dereani [Italie] ; Giuseppe Caruso [Italie] ; Beatrice Montessoro [Italie] ; Marco Taurian [Italie] ; Antonio Di Chiara [Italie] ; Vincenzo Patruno [Italie] ; Francesco Cavallin [Italie] ; Gian Paolo Fadini [Italie] ; Anna Aldovini [États-Unis] ; Anna Baritussio [Italie] ; Francesco Curcio [Italie] ; Carlo Tascini [Italie] ; Aldo Baritussio [Italie]Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center.
000198 (2021) Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie]Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.
000199 (2021) Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie]Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al.
000211 (2021) Sebastian E. Sattui [États-Unis] ; Elizabeth R. Graef [États-Unis] ; Jean W. Liew [États-Unis] ; Jeffrey A. Sparks [États-Unis] ; Alfred H J. Kim [États-Unis]Reply to 'Taking a stand against the politicization of medical research: how "swinging the pendulum" poses a hazard to clinical trials, study participants, and the progress of science'.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "COVID-19 (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "COVID-19 (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    COVID-19 (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021